Close Menu

NEW YORK — Chinese molecular diagnostics firm Burning Rock said on Monday that the underwriters of its recent US initial public offering have exercised their overallotment option, giving the transaction a value of roughly $256.2 million.

Burning Rock also said that investment group Lake Bleu Prime Healthcare Master Fund has purchased a $25 million equity stake in the company. Taken together, the two transactions have raised about $281.2 million for Burning Rock.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.